The mesothelial cell layer lining the peritoneum orchestrates peritoneal homeostasis. Continuous exposure to peritoneal dialysis fluids and episodes of peritonitis may damage the monolayer irreversibly, eventually leading to adhesion formation and fibrosis/sclerosis of the peritoneum. Autologous mesothelial cell transplantation is thought to be one of the options to reduce dysfunction of the peritoneal membrane. In this article we will review the mesothelial cell transplantation experiments performed in the field of peritoneal dialysis and peritonitis. In addition we will focus on the trouble shooting using cultured autologous mesothelial cells for transplantation.
JorresA., TopleyN., WitowskiJ., LiberekT., GahlG.M.Impact of peritoneal dialysis solutions on peritoneal immune defense.Perit Dial Int1992; 13(suppl 2): S291–4.
2.
TopleyN., WilliamsJ.D.Effect of peritoneal dialysis on cytokine production by peritoneal cells.Blood Purif1996; 14: 188–97.
3.
HendersonI.S., CouperI.A., LumsdenA.The effect of shelf life of peritoneal dialysis fluid on ultrafiltration in CAPD. In: GrecaLa, ed. Peritoneal dialysis.Milan, Italy: Wichtig Editore, 1986; 85–6.
SchalkwijkC.G., PosthumaN., ten BrinkH.J., ter WeeP.M., TeerlinkT.Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-pro-ducts, during heat-sterilization of glucose-based peritoneal dialysis fluids.Perit Dial Int1999; 19: 325–33.
6.
CendorogloM., SundaramS., JaberJ.L., PereiraB.J.Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood and polymorphonuclear cell functions in vitro.Am J Kidney Dis1998; 31: 273–82.
7.
DobbieJ.W., AndersonJ.D., HindC.Long-term effects of peritoneal dialysis on peritoneal morphology.Perit Dial Int1994; 14: S16–20.
8.
WilliamsJ.D., GraigK.J., TopleyN.. Morphological changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
9.
Chailley-HeuB., RubioS., RougierJ.P.. Expression of hydrophilic surfactant proteins by mesentery cells in rat and man.Biochem J1997; 328: 251–6.
10.
DobbieJ.W., PavlinaT., LloydJ., JohnsonR.C.Phosphatidylcholine synthesis by peritoneal mesothelium: Its implication for peritoneal dialysis.Am J Kidney Dis1988; 12: 31–6.
11.
YungS., ColesG.A., WilliamsJ.D., DaviesM.The source and possible significance of hyaluronic acid in the peritoneal cavity.Kidney Int1994; 46: 527–33.
12.
YungS., ThomasG.J., StylianouE., WilliamsJ.D., ColesG.A., DaviesM.Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesise and secrete mainly small dermatan sulfate proteoglycans.Am J Pathol1995; 146: 520–9.
13.
FlessnerM.F.The transport barrier in intraperitoneal therapy.Am J Physiol Renal Physiol2005; 288: F433–42.
14.
AroeiraL.S., AguileraA., SelgasR.. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor.Am J Kidney Dis2005; 46: 938–48.
15.
VergerC., LugerA., MooreH.L., NolphK.D.Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.Kidney Int1983; 23: 823–31.
16.
OIaKaufman, RostovshchikovA.S., KranchevA.K., PaukovV.S.[Reaction of rat peritoneal mesothelial cells in aseptic and bacterial peritonitis].Biull Eksp Biol Med1982; 94: 100–4. Russian.
17.
BeavisM.J., WilliamsJ.D., HoppeJ., TopleyN.Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent.Kidney Int1997; 51: 205–15.
18.
CairnsJ.A., WallsA.F.Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.J Clin Invest1997; 99: 1313–21.
19.
HondaK., NittaK., HoritaS., YumuraW., NiheiH.Morphological changes in the vasculature of patients on CAPD with ultrafiltration failure.Nephron1996; 72: 171–6.
20.
MateijsenM.A., Van der WalA.C., HendriksP.M.. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.Perit Dial Int1999; 19: 517–25.
21.
HekkingL.H., ZareieM., DriesprongB.A.. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.J Am Soc Nephrol2001; 12: 2775–86.
22.
PannekeetM.M., ZemelD., KoomenG.C., StruijkD.G., KredietR.T.Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.Perit Dial Int1995; 15: 217–25.
23.
Ho-dac-PannekeetM.M., HiralallJ.K., StruijkD.G., KredietR.T.Longitudinal follow-up of CA125 in peritoneal effluent.Kidney Int1997; 51: 888–93.
24.
KredietR.T.Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.Perit Dial Int2001; 21: 560–7.
25.
Le PooleC.Y., WeltenA.G., WeijmerM.C., ValentijnR.M., van IttersumF.J., ter WeeP.M.Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious.Perit Dial Int2005; 25: S64–8.
26.
FinkelsteinE., JekelJ., TroidleL., Gorban-BrennanN., FinkelsteinF.O., BiaF.J.Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis.Am J Kidney Dis2002; 39: 1278–86.
27.
VisserC.E., Brouwer-SteenbergenJ.J., Schadee-EestermansI.L., MeijerS., KredietR.T., BeelenR.H.Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells.Infect Immun1996; 64: 3425–8.
28.
LameireN., Van BiesenW., Van LandschootM.. Experimental models in peritoneal dialysis: A European experience.Kidney Int1998; 54: 2194–206.
29.
van HinsberghV.W., KooistraT., SchefferM.A., van BockelJ.H., van MuijenG.N.Characterisation and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.Blood1990; 75: 1490–7.
30.
GriesE., KoppJ., ThomaeU., KuhlmannH.Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis.Thromb Haemost1990; 63: 356–60.
31.
SitterT., SpannaglM., SchifflH., HeldE., van HinsberghV.W., KooistraT.Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells.Nephrol Dial Transplant1995; 10: 677–83.
32.
De BoerA.W., LeviM., ReddingiusR.E.. Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis.Pediatr Nephrol1999; 13: 284–7.
33.
GoeddeM., SitterT., SchifflH., BrechtelU., SchrammW., SpannaglM.Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.Perit Dial Int1997; 17: 162–6.
34.
Di PaoloN., SacchiG., VanniL.. Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient.Int J Artif Organs1989; 12: 485–501.
35.
Di PaoloN., VanniL., SacchiG.Autologous implant of peritoneal mesothelium in rabbits and man.Clin Nephrol1990; 34: 179–84.
36.
Di PaoloN., SacchiG., VanniL.. Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients.Nephron1991; 57: 323–31.
37.
HekkingL.H., HarveyV.S., HavenithC.E.. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis.Perit Dial Int2003; 23: 323–30.
NagyJ.A., ShockleyT.R., MasseE.M., HarveyV.S., JackmanR.W.Mesothelial cell-mediated gene therapy: Feasibility of an ex vivo strategy.Gene Ther1995; 2: 393–401.
40.
NagyJ.A., ShockleyT.R., MasseE.M., HarveyV.S., HoffC.M., JackmanR.W.Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface.Gene Ther1995; 2: 402–10.
41.
JackmanR.W., StapletonT.D., MasseE.M.. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium in vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin.Hum Gene Ther1998; 9: 1069–81.
42.
BertramP., TietzeL., HoopmannM., TreutnerK.H., MittermayerC., SchumpelickV.Intraperitoneal transplantation with isologous mesothelial cells for prevention of adhesions.Eur J Surg1999; 165: 705–9.
43.
Foley-ComerA.J., HerrickS.E., Al-MishlabT., PreleC.M., LaurentG.J., MutsaersS.E.Evidence for incorporation of free-floating mesothelial cells as a mechanism for serosal healing.J Cell Sci2002; 115: 1383–9.
44.
AsanoT., TakazawaR., YamatoM.. Transplantation of an autologous mesothelial cell sheet prepared from tunica vaginalis prevents post-operative adhesions in a canine model.Tissue Eng2006; 12: 2629–37.
45.
HoffC.M., ShockleyT.R.Peritoneal dialysis in the 21st century. The potential of gene therapy.J Am Soc Nephrol2002; 13(suppl): S117–24.
46.
Lopéz-CabreraM., AguileraA., AroeiraL.S.. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.Perit Dial Int2006; 26: 26–34.
47.
SelgasR., BajoA., Jimenez-HeffernanJ.A.. Epithelial-to-mesenchymal transition of the mesothelial cell its role in the response of the peritoneum to dialysis.Nephrol Dial Transplant2006; 21: ii2–7.
48.
NevadoJ., VallejoS., El-AssarM., PeiroC., Sanchez-FerrerC.F., Rodriquez-ManasL.Changes in the human peritoneal mesothelial cells during aging.Kidney Int2006; 69: 313–22.
49.
HendersonI.S., DobbieJ.W., ZakiM.A., WilsonL.S.Structure of the peritoneum and changes brought about by infection.Contrib Nephrol1987; 57: 30–40.
50.
VisserC.E., SteenbergenJ., BetjesM.G., KoomenG.C., BeelenR.H., KredietR.Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.Nephrol Dial Transplant1995; 10: 64–9.
51.
VisserC.E., Brouwer-SteenbergenJ.J., PostmusP.E.. Renal function influences interleukin-8 background production by cultured human mesothelial cells.Adv Perit Dial1996; 12: 15–8.
52.
HerrickS.E., MutsaersS.E.Mesothelial progenitor cells and their potential in tissue engineering.Int J Biochem Cell Biol2004; 36: 621–42.
